“The Simplest Way to Go”: An Exploration of Why Women Who Inject Drugs Chose Long-Acting Injectable Cabotegravir Instead of Daily Oral PrEP
AIDS and Behavior · 2025
DOI: 10.1007/s10461-025-04833-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Alexis M Roth und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market Street, Philadelphia, PA, 19104, USA.…. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Substance Abuse, Intravenous, Pyridones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Intramural Research Program, National Institute on Drug Abuse.
Abstract (Originalsprache)
Long-acting injectable PrEP was approved for use in the US in 2021 but roll out has been slow, with few studies exploring uptake among cisgender women who inject drugs (WWID). We purposively recruited 25 WWID within 30-days of receiving a PrEP prescription from a low-barrier clinic co-located with a syringe services program to complete semi-structured interviews about PrEP product choice. We used an intersectional lens to compare decision-making between women choosing injectable PrEP versus oral PrEP and continued enrolling new participants until we reached thematic saturation (12/2022 to 2/2024). Participants represent a diverse sample of WWID (12 women of color) with median age 43 years. Daily injection drug use (72%) and ≥ 1 sex partner (64%) were common. Salient themes from interviews include: (1) PrEP provides women with a valued safety net and initiation is a form of self-preservation. (2) Co-located care, small incentives, and provider respect for WWID's medical autonomy helped participants navigate a multi-visit PrEP intake process. (3) Longer lasting HIV protection with less frequent dosing is preferrable to a shorter acting daily oral medication. When selecting a product, WWID evaluated its attributes against their medical history and personal circumstances like homelessness (64%). Most chose CAB-LA (72%) because it provides longer lasting protection which was a highly valued product attribute. Together, our findings underscore the critical importance of offering multiple PrEP options when implementing HIV prevention strategies that are patient-centered and responsive to the unique needs of WWID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market Street, Philadelphia, PA, 19104, USA. amr395@drexel.edu.
- Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market Street, Philadelphia, PA, 19104, USA.
- Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, MI, USA.
- Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
- Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
- Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Förderung
- NIDA NIH HHS
- Intramural Research Program, National Institute on Drug Abuse
Zitieren
APA
Roth, A. M., Ward, K. M., McDowell, E., Forman, E., Amico, K. R., Bartholomew, T. S., Krakower, D., Vader, D., Mazzella, S., Carrico, A. W., Sherman, S. G., & Groves, A. (2025). “The Simplest Way to Go”: An Exploration of Why Women Who Inject Drugs Chose Long-Acting Injectable Cabotegravir Instead of Daily Oral PrEP. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04833-5
Vancouver
Roth AM, Ward KM, McDowell E, Forman E, Amico KR, Bartholomew TS, et al. “The Simplest Way to Go”: An Exploration of Why Women Who Inject Drugs Chose Long-Acting Injectable Cabotegravir Instead of Daily Oral PrEP. AIDS and Behavior. 2025. doi:10.1007/s10461-025-04833-5
BibTeX
@article{Roth2025,
author = {Roth, Alexis M and Ward, Kathleen M and McDowell, Erin and Forman, Elana and Amico, K Rivet and Bartholomew, Tyler S and Krakower, Douglas and Vader, Daniel and Mazzella, Silvana and Carrico, Adam W and Sherman, Susan G and Groves, Allison},
title = {“The Simplest Way to Go”: An Exploration of Why Women Who Inject Drugs Chose Long-Acting Injectable Cabotegravir Instead of Daily Oral PrEP},
journal = {AIDS and Behavior},
year = {2025},
doi = {10.1007/s10461-025-04833-5}
}
EUVIMED